JNPR
59
3
O
26
16
CCL
68
6
KLAC
45
3
WM
53
2
HSIC
42
2
MTCH
62
22
WAT
55
11
UNH
42
6
APH
53
3
CHD
34
7
ESS
44
5
NVDA
52
5
PRU
39
3
BIIB
36
8
CAH
44
7
EIX
61
8
LH
33
3
BAX
38
2
AMGN
42
14
JNPR
59
3
O
26
16
CCL
68
6
KLAC
45
3
WM
53
2
HSIC
42
2
MTCH
62
22
WAT
55
11
UNH
42
6
APH
53
3
CHD
34
7
ESS
44
5
NVDA
52
5
PRU
39
3
BIIB
36
8
CAH
44
7
EIX
61
8
LH
33
3
BAX
38
2
AMGN
42
14
Financhill
Back

Exact Sciences Quote, Financials, Valuation and Earnings

The Trump Nuclear MEGA-Boom!

Here's why nuclear stocks are expected to skyrocket under Trump's second term.
Sell
41

EXAS
Exact Sciences

Last Price:
$59.41
Seasonality Move:
15.47%

7 Day Trial

ALL ACCESS PASS

$ 7

The AI Energy Miracle

Details Here.

Exact Sciences Price Quote

$59.41
+0.05 (+5.88%)
(Updated: December 21, 2024 at 5:25 AM ET)

Exact Sciences Key Stats

Sell
41
Exact Sciences (EXAS) is a Sell
Day range:
$55.98 - $59.70
52-week range:
$40.62 - $79.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.04
P/B ratio:
3.42%
Volume:
2.9M
Avg. volume:
2.7M
1-year change:
-11.8%
Market cap:
$11B
Revenue:
$2.5B
EPS:
$-1.17

How Much Does Exact Sciences Make?

Data Unavailable

Is Exact Sciences Growing As A Company?

Data Unavailable

Exact Sciences Stock Price Performance

  • Did Exact Sciences Stock Go Up Last Month?
    Exact Sciences share price went up by 12.64% last month
  • Did EXAS's Share Price Rise Over The Last Year?
    EXAS share price fell by -11.8% over the past 1 year

What Is Exact Sciences 52-Week High & Low?

Exact Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Exact Sciences?

Data Unavailable

Is Exact Sciences Cash Flow Positive?

Data Unavailable

Exact Sciences Return On Invested Capital

Data Unavailable

Exact Sciences Earnings Date & Stock Price

Exact Sciences Competitors

  • Who Are Exact Sciences's Competitors?
    Below is a list of companies who compete with Exact Sciences or are related in some way:
    • Delcath Systems Inc (DCTH)
    • Quest Diagnostics Inc (DGX)
    • Guardant Health Inc (GH)
    • Illumina Inc (ILMN)
    • Progyny Inc (PGNY)

Exact Sciences Dividend Yield

Data Unavailable

Exact Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -33.33%
Revenue: 12.78% -1.16%

Analyst Recommendations

Buy Recommendations: 17
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 71.86
Upside from Last Price: 21.05%

Major Shareholders

Data Unavailable